学习园地

Magstim Horizon Inspire经颅磁刺激系统获英国UKCA认证

发布时间：2025-05-30 09:52:48   来源：本站   点击：12次

　　适用于重性抑郁症(MDD)、强迫症(OCD)及焦虑症状的临床治疗

　　英国卡马森郡——(2024年12月5日)——全球神经科学研究和精神健康治疗领导者Magstim宣布，Horizon Inspire系统正式获得英国UKCA认证。该系统将为NHS体系及英国私立医疗机构提供新一代经颅磁刺激(TMS)治疗方案，用于治疗重性抑郁症、强迫症及焦虑症状*。

　　权威专家评价

　　"作为将TMS技术引入NHS体系的先驱，我们持续推动抑郁症治疗的创新突破，"Transforming Mind Solutions医疗总监Alex O'Neill Kerr教授(MBChB)表示，"Horizon Inspire系统在经典Magstim技术基础上实现了全面升级，将显著提升临床疗效。"

　　三十年技术传承

　　Magstim首席执行官Ronnie Stolec-Campo强调："我们为NHS提供TMS技术已逾三十载。经颅磁刺激作为一种副作用极小的有效疗法，其临床价值已获充分验证。Inspire系统既能满足资深TMS医师的高端需求，也可帮助新用户快速掌握操作流程。"

　　技术优势

　　• 高效风冷系统支持连续定制化治疗

　　• 一体化便携设计实现多诊室灵活调配

　　• 操作简捷且具卓越成本效益

　　• 全球20000+同行评审研究引证其科学价值

　　行业趋势

　　最新研究数据显示，经颅磁刺激在治疗重性抑郁症和强迫症方面展现显著优势，推动该技术在全球医疗机构的加速普及。

　　Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved By UKCA For NHS & Private UK Clinics Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved By UKCA For NHS & Private UK Clinics UK System for Patient Treatment of MDD, OCD and Decreasing Anxiety* Carmarthenshire, UK -- (December 5, 2024) – Magstim, the global leader in neuroscience research and treatment for mental health, has been awarded UKCA clearance for the Horizon Inspire System, continuing to provide NHS physicians and researchers with next-generation transcranial magnetic stimulation technology to treat patients with MDD, OCD and Decreasing Anxiety*. “As the first to introduce clinical TMS into the NHS, our team continues delivering innovative treatments to help treat depression and anxiety,” said Professor Alex O’Neill Kerr, MBChB, Medical Director of Transforming Mind Solutions. “This new system takes trusted Magstim TMS technology to the next level, improving patient outcomes.” “Magstim has supplied the NHS with TMS technology for more than 30 years,” said Ronnie Stolec-Campo, CEO, Magstim. “Transcranial magnetic stimulation is a proven and effective treatment with minimal side effects. The Inspire enables both experienced TMS providers as well as those who are new to TMS to get up a running fast to provide patient treatments.” The Inspire provides high-power air-cooling, ability to deliver back-to-back customizable treatments, all while being easy to use, cost-effective and offering portability between clinic rooms. Magstim TMS technology is cited in more than 20,000 peer reviewed research papers and used in hospitals, clinics and research centers worldwide. The use of Transcranial Magnetic Stimulation for treating MDD and OCD is increasing worldwide, driven by new studies demonstrating its effectiveness over other treatments (**).